Citadel Advisors »

Pasithea Therapeutics Corp shares owned by Citadel Advisors

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTAW) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $206 15k 0.01
2025-06-30 $335 16k 0.02
2024-06-30 $143 13k 0.01
2024-03-31 $162 13k 0.01
2023-12-31 $235 13k 0.02
2023-09-30 $189 13k 0.01

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Pasithea Therapeutics Corp

Kepos Capital
Armistice Capital
Marex Group
Citadel Advisors
Susquehanna International
Clear Street

View all funds holding Pasithea Therapeutics Corp